Boston Scientific gains approval for asthma device in China

10/25/2013 | MassDevice.com (Boston)

Chinese regulators have granted Boston Scientific approval to market its Alair Bronchial Thermoplasty device in that country. The device, which the company acquired through its $193.5 million purchase of Asthmatx in 2010, is designed to treat severe asthma patients who have failed to respond to long-acting beta-agonists or inhaled corticosteroids.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Director, Quality Regulatory Affairs
Cardinal Health
Chicago, IL
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC